Fortress Biotech, Inc.FBIONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank20
3Y CAGR-45.2%
5Y CAGR-19.1%
Year-over-Year Change
Research and development spending
3Y CAGR
-45.2%/yr
vs +11.5%/yr prior
5Y CAGR
-19.1%/yr
Recent deceleration
Acceleration
-56.6pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.21M | -61.0% |
| 2024 | $56.88M | -46.4% |
| 2023 | $106.07M | -21.4% |
| 2022 | $134.88M | +4.7% |
| 2021 | $128.87M | +101.0% |
| 2020 | $64.11M | -21.2% |
| 2019 | $81.33M | -6.9% |
| 2018 | $87.38M | +66.5% |
| 2017 | $52.49M | +49.4% |
| 2016 | $35.13M | - |